Cargando…
Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by Clostridium perfringens enterotoxin (CPE) leads to activation of the transcriptional co-...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313056/ https://www.ncbi.nlm.nih.gov/pubmed/32481659 http://dx.doi.org/10.3390/ijms21113840 |
_version_ | 1783549871032107008 |
---|---|
author | Fujiwara-Tani, Rina Fujii, Kiyomu Mori, Shiori Kishi, Shingo Sasaki, Takamitsu Ohmori, Hitoshi Nakashima, Chie Kawahara, Isao Nishiguchi, Yukiko Mori, Takuya Sho, Masayuki Kondoh, Masuo Luo, Yi Kuniyasu, Hiroki |
author_facet | Fujiwara-Tani, Rina Fujii, Kiyomu Mori, Shiori Kishi, Shingo Sasaki, Takamitsu Ohmori, Hitoshi Nakashima, Chie Kawahara, Isao Nishiguchi, Yukiko Mori, Takuya Sho, Masayuki Kondoh, Masuo Luo, Yi Kuniyasu, Hiroki |
author_sort | Fujiwara-Tani, Rina |
collection | PubMed |
description | Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by Clostridium perfringens enterotoxin (CPE) leads to activation of the transcriptional co-activator yes-associated protein (YAP) in oral squamous cell carcinoma. Here, we investigated whether CPE activates YAP to promote the malignant progression of SSA/P. E-cadherin expression was lower in the 12 cases with SSA/P-D examined than that in normal mucosa, SSA/P, or tubular adenoma (TA). Furthermore, intracellular translocation of claudin-4 (CLDN4) and nuclear translocation of YAP were observed. The CPE gene was detected in DNA extracted from SSA/P-D lesions, but not in SSA/P or TA. Treatment of the rat intestinal epithelial cell line IEC6 with low-dose CPE resulted in intracellular translocation of CLDN4 to the cytoplasmic membrane. Cytoplasmic CLDN4 showed co-precipitation with transcriptional co-activator with PDZ-binding motif, zonula occludens (ZO)-1, large tumor suppressor, and mammalian Ste20-like. Additionally, YAP co-precipitated with ZO-2 under CPE treatment led to decreased YAP phosphorylation and nuclear translocation. YAP activation promoted increase in nuclear TEA domain family member level, expression of cyclin D1, snail, vimentin, CD44, NS and decrease in E-cadherin levels, thereby inducing stemness and epithelial-mesenchymal-transition (EMT). The Hippo complex with the incorporation of CLDN4 increased stability. Upon low-dose CPE treatment, HT29 cells with BRAF(V600E) gene mutation showed increased growth, enhanced invasive potential, stemness, and induced EMT phenotype, whereas HCT116 cells, which carry KRAS(G13D) gene mutation, did not show such changes. In an examination of 10 colorectal cancers, an increase in EMT and stemness was observed in CPE (+) and BRAF mutation (+) cases. These findings suggest that C. perfringens might enhance the malignant transformation of SSA/P-D via YAP activation. Our findings further highlight the importance of controlling intestinal flora using probiotics or antibiotics. |
format | Online Article Text |
id | pubmed-7313056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73130562020-06-29 Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia Fujiwara-Tani, Rina Fujii, Kiyomu Mori, Shiori Kishi, Shingo Sasaki, Takamitsu Ohmori, Hitoshi Nakashima, Chie Kawahara, Isao Nishiguchi, Yukiko Mori, Takuya Sho, Masayuki Kondoh, Masuo Luo, Yi Kuniyasu, Hiroki Int J Mol Sci Article Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by Clostridium perfringens enterotoxin (CPE) leads to activation of the transcriptional co-activator yes-associated protein (YAP) in oral squamous cell carcinoma. Here, we investigated whether CPE activates YAP to promote the malignant progression of SSA/P. E-cadherin expression was lower in the 12 cases with SSA/P-D examined than that in normal mucosa, SSA/P, or tubular adenoma (TA). Furthermore, intracellular translocation of claudin-4 (CLDN4) and nuclear translocation of YAP were observed. The CPE gene was detected in DNA extracted from SSA/P-D lesions, but not in SSA/P or TA. Treatment of the rat intestinal epithelial cell line IEC6 with low-dose CPE resulted in intracellular translocation of CLDN4 to the cytoplasmic membrane. Cytoplasmic CLDN4 showed co-precipitation with transcriptional co-activator with PDZ-binding motif, zonula occludens (ZO)-1, large tumor suppressor, and mammalian Ste20-like. Additionally, YAP co-precipitated with ZO-2 under CPE treatment led to decreased YAP phosphorylation and nuclear translocation. YAP activation promoted increase in nuclear TEA domain family member level, expression of cyclin D1, snail, vimentin, CD44, NS and decrease in E-cadherin levels, thereby inducing stemness and epithelial-mesenchymal-transition (EMT). The Hippo complex with the incorporation of CLDN4 increased stability. Upon low-dose CPE treatment, HT29 cells with BRAF(V600E) gene mutation showed increased growth, enhanced invasive potential, stemness, and induced EMT phenotype, whereas HCT116 cells, which carry KRAS(G13D) gene mutation, did not show such changes. In an examination of 10 colorectal cancers, an increase in EMT and stemness was observed in CPE (+) and BRAF mutation (+) cases. These findings suggest that C. perfringens might enhance the malignant transformation of SSA/P-D via YAP activation. Our findings further highlight the importance of controlling intestinal flora using probiotics or antibiotics. MDPI 2020-05-28 /pmc/articles/PMC7313056/ /pubmed/32481659 http://dx.doi.org/10.3390/ijms21113840 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fujiwara-Tani, Rina Fujii, Kiyomu Mori, Shiori Kishi, Shingo Sasaki, Takamitsu Ohmori, Hitoshi Nakashima, Chie Kawahara, Isao Nishiguchi, Yukiko Mori, Takuya Sho, Masayuki Kondoh, Masuo Luo, Yi Kuniyasu, Hiroki Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia |
title | Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia |
title_full | Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia |
title_fullStr | Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia |
title_full_unstemmed | Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia |
title_short | Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia |
title_sort | role of clostridium perfringens enterotoxin on yap activation in colonic sessile serrated adenoma/polyps with dysplasia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313056/ https://www.ncbi.nlm.nih.gov/pubmed/32481659 http://dx.doi.org/10.3390/ijms21113840 |
work_keys_str_mv | AT fujiwaratanirina roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT fujiikiyomu roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT morishiori roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT kishishingo roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT sasakitakamitsu roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT ohmorihitoshi roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT nakashimachie roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT kawaharaisao roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT nishiguchiyukiko roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT moritakuya roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT shomasayuki roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT kondohmasuo roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT luoyi roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia AT kuniyasuhiroki roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia |